13FPulse
中
CT

CTNM CONTINEUM THERAPEUTICS INC-A

2026Q2 · CUSIP 21217B100 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
101
Institutions that reported holding it to the SEC
Net increase in holders
+12
Last quarter 89 → now 101
How unusual is that
Above average
Stronger buying than 73% of US stocks
What the filings say, in one paragraph

101 funds held CTNM at the end of 2026Q2, up 12 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, return on equity is -24.0%. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2024Q3: holders=51 2024Q4: holders=62 2025Q1: holders=63 2025Q2: holders=71 2025Q3: holders=62 2025Q4: holders=80 2026Q1: holders=89 2026Q2: holders=101 -18 -9 +0 +9 +18 4576107 24Q324Q425Q125Q225Q325Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush

This stock has never had a buying rush

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
53
Change in large funds
+12
Total value they hold
$500M
Funds buying for the first time
30
Funds that sold out entirely
18
Price change that quarter
+34.1%
Funds holding puts (bearish)
0
Funds holding calls (bullish)
1

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.72
EPS YoY
-430.8%
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-24.0%
Debt ratio
4.3%
FCF (TTM)
-$53M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2024-06-30: EPS -0.39 2024-09-30: EPS -0.40 2025-03-31: EPS -0.62 2025-06-30: EPS -0.62 2025-09-30: EPS -0.45 2025-12-31: EPS -0.48 2026-03-31: EPS -0.39 2026-06-30: EPS -0.40 -0.68 -0.34 0.00 20242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-17M12M41M 2023202420252026
Latest quarter $-17M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.